HPSE and breast carcinoma: Importantly, compound 4-MMI yielded a nearly fourfold inhibition of 4T1 breast carcinoma metastasis, comparable to the effect exerted by Roneparstat (=SST), a well-characterized heparin-like heparanase inhibitor (Figure 4) [15,17,33,36,39,41].